1. Rongxin China (03301.HK) first 8 months total contract sales of about 2.70 billion yuan, down 46.4%. 2. Fosun International (00656.H...

< Span class = "section-news" > 1. Rongxin China (03301.HK) 's total contract sales in the first 8 months were about 2.70 billion yuan, down 46.4% year-on-year. < br > < span class = "section-news" > 2. Fosun International (00656.HK): Fidelidade, a subsidiary, sold 40% of its shares 310 million euros. < br > < span class = "section-news" > 3. Guofu Quantum (00290.HK) intends to discount about 16.43% of the 745 million shares, with a net raise of about 1.3214 billion Hong Kong dollars. < br > < span class = "section-news" > 4. Gemdale Commercial (00535.HK): The cumulative contract sales in the first 8 months were about 7.588 billion yuan, a year-on-year decrease of 38.97%. < br > < span class = "section-news" > 5. Hongyang Real Estate (01996.HK): The cumulative contract sales in the first 8 months were 3.506 billion yuan, a year-on-year decrease of 42.24%. < br > < span class = "section-news" > 6. China Overseas Grand Ocean Group (00081.HK): The cumulative contract sales in the first 8 months were 20.783 billion yuan, a year-on-year decrease of 10.6%. < br > < span class = "section-news" > 7. Truly International (00732.HK): The cumulative consolidated net operating income in the first 8 months was approximately HK $11.011 billion, a decrease of about 5.5% year-on-year. < br > < span class = "section-news" > 8. China Overseas Development (00688.HK): The cumulative contract property sales amount in the first 8 months was about 150.331 billion yuan, a decrease of 16.5% year-on-year. < br > < span class = "section-news" > 9. Hengrui Pharmaceutical (01276.HK) and Braveheart Bio signed the HR-1893 project licensing agreement.